Patient-specific spine implant nabs additional CMS reimbursement approval

Carlsmed’s patient-specific spine implant, Aprevo, received a transitional pass-through payment from CMS.

Advertisement

This provides outpatient facilities with an incremental Medicare payment for procedures that use Aprevo, according to an Oct. 19 news release. The designation is part of CMS’ quarterly update of the 2021 Medicare Hospital Outpatient Prospective Payment System.

The nod comes weeks after CMS granted the new technology add-on payment. Both payment reimbursement programs went into effect Oct. 1.

Advertisement

Next Up in Spinal Tech

  • Zavation Medical has acquired ChoiceSpine, and Derek Kuyper will be CEO of the combined company, according to a Feb. 26…

  • Carlsmed saw significant gains in fourth-quarter and 2025 revenue, according to financial results posted Feb. 25. Five things to know:…

Advertisement

Comments are closed.